Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients (pts) with muscle invasive bladder cancer (MIBC): Updated results for Cohort H Meeting Abstract
| Authors: | Flaig, T. W.; Rosenberg, J. E.; Hoimes, C. J.; O'Donnell, P. H.; Mar, N.; Gourdin, T. S.; Henry, S.; Bilen, M. A.; George, S.; Barata, P. C.; Srinivas, S.; Rao, S. K.; Assikis, V. J.; Burgess, E. F.; Ramamurthy, C.; Haas, G. P.; Lukas, J. J.; Mildiner-Earley, S.; Yu, Y.; Petrylak, D. P. |
| Abstract Title: | Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients (pts) with muscle invasive bladder cancer (MIBC): Updated results for Cohort H |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.4595 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 4595 -- This meeting was also held virtually -- Source: Cinahl |
